BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21591267)

  • 1. Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications.
    Zürbig P; Dihazi H; Metzger J; Thongboonkerd V; Vlahou A
    Proteomics Clin Appl; 2011 Jun; 5(5-6):256-68. PubMed ID: 21591267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of urinary proteomics/peptidomics.
    Albalat A; Mischak H; Mullen W
    Expert Rev Proteomics; 2011 Oct; 8(5):615-29. PubMed ID: 21999832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
    Mischak H; Delles C; Klein J; Schanstra JP
    Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary proteomics: towards biomarker discovery, diagnostics and prognostics.
    Thongboonkerd V
    Mol Biosyst; 2008 Aug; 4(8):810-5. PubMed ID: 18633482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic potential of urine proteome: a broken mirror of renal diseases.
    Goligorsky MS; Addabbo F; O'Riordan E
    J Am Soc Nephrol; 2007 Aug; 18(8):2233-9. PubMed ID: 17625117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary exosomes and proteomics.
    Moon PG; You S; Lee JE; Hwang D; Baek MC
    Mass Spectrom Rev; 2011; 30(6):1185-202. PubMed ID: 21544848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis in pediatric renal disease.
    Traum AZ; Schachter AD
    Semin Nephrol; 2007 Nov; 27(6):652-7. PubMed ID: 18061847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: Serum and urine biomarkers of kidney disease: A pathophysiological perspective.
    Tesch GH
    Nephrology (Carlton); 2010 Sep; 15(6):609-16. PubMed ID: 20883281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for.
    Spasovski G; Ortiz A; Vanholder R; El Nahas M
    Proteomics Clin Appl; 2011 Jun; 5(5-6):233-40. PubMed ID: 21538916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary proteomics: a tool to discover biomarkers of kidney diseases.
    Dihazi H; Müller GA
    Expert Rev Proteomics; 2007 Feb; 4(1):39-50. PubMed ID: 17288514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards the application of proteomics in renal disease diagnosis.
    Vidal BC; Bonventre JV; I-Hong Hsu S
    Clin Sci (Lond); 2005 Nov; 109(5):421-30. PubMed ID: 16232126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proteomics and the kidney: an innovative approach to the study of renal disease].
    Netti GS; Rocchetti MT; Papale M; Centra M; Centonze D; Di Paolo S; Ranieri E; Gesualdo L
    G Ital Nefrol; 2008; 25(2):169-82. PubMed ID: 18350497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic methods for biomarker discovery in urine.
    Wilkey DW; Merchant ML
    Semin Nephrol; 2007 Nov; 27(6):584-96. PubMed ID: 18061841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CE-MS in biomarker discovery, validation, and clinical application.
    Mischak H; Schanstra JP
    Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.
    Schiffer E; Mischak H; Novak J
    Proteomics; 2006 Oct; 6(20):5615-27. PubMed ID: 16991199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary proteomics.
    González-Buitrago JM; Ferreira L; Lorenzo I
    Clin Chim Acta; 2007 Jan; 375(1-2):49-56. PubMed ID: 16942764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery.
    Thongboonkerd V
    Expert Rev Proteomics; 2005 Jun; 2(3):349-66. PubMed ID: 16000082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of Fabry disease nephropathy.
    Schiffmann R; Waldek S; Benigni A; Auray-Blais C
    Clin J Am Soc Nephrol; 2010 Feb; 5(2):360-4. PubMed ID: 19965549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of urinary proteomics in biomarker discovery.
    Shao C; Wang Y; Gao Y
    Sci China Life Sci; 2011 May; 54(5):409-17. PubMed ID: 21455690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
    Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
    Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.